Clinical Trial Update: Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating AV-001 for HD-induced brain injury, currently recruiting at London Health Sciences Centre Research Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• AV-001

Snippet

Sponsor: London Health Sciences Centre Research Institute | Conditions: Hemodialysis | Phase 2 | Status: RECRUITING